Computational approaches to identify common subunit vaccine candidates against bacterial meningitis

Manne Munikumar1, I Vani Priyadarshini, Dibyabhaba Pradhan

  • 1SVIMS Bioinformatics Centre, Department of Bioinformatics, SVIMS University, Tirupati 517507, AP, India.

Insights

A novel T-cell epitope from a common bacterial meningitis protein offers a promising target for a universal vaccine. This conserved epitope, identified through proteomic and computational analysis, could lead to broader protection against this deadly disease.

Area of Science:

  • * Immunology
  • * Vaccinology
  • * Computational Biology

Background:

  • * Bacterial meningitis is a leading cause of global mortality and disability.
  • * Current vaccines target specific serogroups/serotypes, limiting broad protection.
  • * Four key pathogens: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, and Staphylococcus aureus.

Purpose of the Study:

  • * To identify common targets for a universal bacterial meningitis vaccine.
  • * To investigate conserved surface-exposed proteins for potential T-cell epitopes.
  • * To evaluate the suitability of identified epitopes for vaccine development.

Main Methods:

  • * Comparative proteomic analysis of four bacterial meningitis pathogens.
  • * In silico prediction and validation of promiscuous T-cell epitopes using Pro-Pred, SYFPEITHI, and IEDB.
  • * Structural analysis including protein modeling, molecular docking (Glide), and molecular dynamics simulations (Desmond).

Main Results:

  • * Seven common surface-exposed ABC transporter proteins were identified.
  • * A conserved T-cell epitope (162-FMILPIFNV-170) from the potH protein was found across all four pathogens.
  • * Computational docking and simulation confirmed stable interaction between the epitope and HLA-DRB alleles.

Conclusions:

  • * The identified T-cell epitope (162-FMILPIFNV-170) is a strong candidate for a T-cell driven subunit vaccine.
  • * This epitope's conservation across major bacterial meningitis pathogens suggests potential for a universal vaccine.
  • * Further development of this epitope could significantly impact bacterial meningitis prevention.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...